What factors affect a sufficient dose of glipizide?

Glipizide is an oral antidiabetic or antihyperglycaemic treatment of the type of sulphonylmoch used to treat diabetes mellitus type 2, also known as the name for adults or non -insolin dependent diabetes. Medicines work by stimulating insulin production in the pancreas. The newly produced insulin helps to reduce blood glucose levels by stimulating cells in the body to increase their glucose intake for storage or metabolism. The standard dose of glipizide is collected twice a day, 30 minutes before meals, although there is a version with an extended version that is taken only once a day. The specific prescribed glipizide dose depends on the representative level of blood glucose, its adherence to the recommended diabetic diet, whether exercise program, its body weight and other factors that can affect blood glucose or drug efficiency.

The doctor prescribes or recommends a given dose of glipizide based on the usual deduction of glucose in the patient's blood; Initial dHowever, when the first drugs started, they may be lower so that the patient can get used to the side effects of the drug. Once the glipizide dose has reached the expected amount, other factors come into play to determine whether this dose is sufficient and sufficient to reduce blood glucose. A drug that increases insulin levels and reduces blood glucose is not a patient license to freely eat high sugar and foods of high carbohydrates. The patient must maintain their prescribed diabetic diet to reduce the level of glucose at the level of nutrition. It must also maintain or initiate an agreed exercise program that helps naturally reduce blood glucose levels.

patients obese may require a higher dose of glipizide than normal weight diabetics with the same blood glucose levels. This is secondary to illness as metabolic syndrome, insulin resistance syndrome or X syndrome. Diabetic patients with insulin resistance syndrome usually carry another weight around the center of the body.Although glipizide treatment stimulates the pancreas to produce insulin, it cannot affect the movement of glucose from the bloodstream into the body cells. The effects of this syndrome can be reduced by exercise and weight loss.

chronic or concurrent diseases may affect the dose of patient glipiside. Many diseases of the liver, kidney or hormonal disease can reduce the amount of glipiside prescribed or contraindicates drugs completely. Temporary changes in the condition of a diabetic patient may require a change in its dosage. In addition, many drugs can interact with glipizide and some should not be used with this drug at all. For these reasons, it is essential that the physician and the pharmacist review the patient's medical history and all medicines or supplements, both prescribed and relocation.